Tag:
John Kasteltein
Latest Headlines
Latest Headlines
Insurers, PBMs mull Vytorin data
Insurers could bring the axe down hard on Vytorin and Zetia. In light of the anti-ezetimibe recommendations from an American College of Cardiology panel and the New England Journal of Medicine,
